Khoom npe:Olivetol
Lwm Lub Npe:3,5-dihydroxyamylbenzene hmoov;
5-Pentyl-1,3-benzenediol;
5-Pentylresorcinol.
Pentyl-3,5-dihydroxybenzene
CAS Nr:500-66-3
Specifications: 98.0%
Xim:Xim av liabhmoov nrog cov yam ntxwv tsw thiab saj
GMO Status: GMO Dawb
Ntim: hauv 25kgs fiber ntau nruas
Cia: Khaws lub thawv tsis qhib hauv qhov chaw txias, qhuav, Khaws kom deb ntawm lub teeb muaj zog
Lub neej txee: 24 lub hlis txij li hnub tsim khoom
Olivetol, tseem hu ua 5-pentylresorcinol los yog 5-pentyl-1,3-benzenediol, yog ib qho organic compound pom nyob rau hauv qee hom lichen; nws kuj yog ib tug precursor nyob rau hauv ntau yam syntheses o
Olivetol yog ib txwm tshwm sim organic compound. Nws muaj nyob rau hauv qee hom ntawm lichens thiab tuaj yeem muab rho tawm yooj yim.
Olivetol yog ib tug natural polyphenolic compound pom nyob rau hauv lichens los yog tsim los ntawm tej kab. yog ib qho tshwm sim tshwm sim thaum chiv thawj tsim los ntawm degrading lichenic acid (tseem hu ua D-cerosol acid thiab valeric acid) muab rho tawm los ntawm cov nroj tsuag lichen thiab siv feem ntau hauv kev sim thiab kev tsim tshuaj. Olive cawv muaj ntau yam kev ua ub no thiab muaj txiaj ntsig zoo rau ntau yam
ntawm pathogenic fungi thiab kab mob. Qhov no organic compound belongs rau tsev neeg resorcinol.
Muaj nuj nqi:
Nws ntseeg tau tias Olivetol ua raws li kev sib tw inhibitor ntawm CB1 thiab CB2 receptors. Vim nws qhov me me thiab nws tsis muaj ntau pab pawg ua haujlwm, nws ntseeg tias Olivetol khi ntau nruj thiab / lossis ntau dua aggressively rau cov receptors CB1 thiab / lossis CB2 thiab muaj qhov sib txawv qis dua, cia nws nyob hauv qhov chaw nquag. ntawm CB receptors rau lub sijhawm ntev dua thaum tsis ua kom lub receptor, yog li tsis ua rau muaj kev hloov pauv hauv GABA tso tawm uas ntseeg tau tias yog lub luag haujlwm ntawm THC cov teebmeem psychotropic.
Daim ntawv thov:
Olivetol tau siv los ua tus qauv molecule hauv kev sib txuas ntawm molecularly imprinted polymer, Nws kuj tau siv los ua tus inhibitor ntawm (S)-mephenytoin 4′-hydroxylase kev ua ntawm recombinant CYP2C19.
